Chronic low back pain (cLBP) is one of the most common forms of chronic pain in the world, but treatment options are largely ineffective.  The Back Pain Consortium (BACPAC) research program, sponsored by the National Institutes of Health, intends to remedy this.  Its goals include developing models for predicting cLBP that involves biological, biomechanical, psychosocial, and other inputs, as well as identifying factors related to treatment effectiveness.

 

The benefits being derived by this comprehensive effort are far-reaching, both in terms of LBP treatment and prevention.  The Center for Disruptive Musculoskeletal Innovations (CDMI) invites you to take part in a free symposium that will highlight the significance of BACPAC data and technology resources.  It is an opportunity for industry, researchers, and clinical groups alike to learn more about BACPAC and brainstorm with others regarding methods to take advantage of this knowledge.   Those who seek to prevent individuals from developing cLBP, treat patients with musculoskeletal pain, or use technology to monitor treatment responses will find this event to be of value.